Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer.

Krupitskaya Y, Loo BW Jr.

Curr Treat Options Oncol. 2008 Dec;9(4-6):343-56. doi: 10.1007/s11864-009-0090-8. Epub 2009 Apr 22. Review.

PMID:
19387842
2.

Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data.

Le Péchoux C.

Oncologist. 2011;16(5):672-81. doi: 10.1634/theoncologist.2010-0150. Epub 2011 Mar 4. Review.

3.

Post-operative radiation therapy.

Paumier A, Le Péchoux C.

Transl Lung Cancer Res. 2013 Oct;2(5):423-32. doi: 10.3978/j.issn.2218-6751.2013.10.03. Review.

4.
5.

Postoperative radiotherapy for patients with completely resected pathologic n2 non-small-cell lung cancer: a retrospective analysis.

Mantovani C, Levra NG, Filippi AR, Novello S, Buffoni L, Ragona R, Ricardi U.

Clin Lung Cancer. 2013 Mar;14(2):194-9. doi: 10.1016/j.cllc.2012.05.007. Epub 2012 Aug 11.

PMID:
22885347
6.

Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.

Péchoux CL, Mercier O, Belemsagha D, Bouaita R, Besse B, Fadel E.

EJC Suppl. 2013 Sep;11(2):123-30. doi: 10.1016/j.ejcsup.2013.07.022. Review.

7.

Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.

Matsuguma H, Nakahara R, Ishikawa Y, Suzuki H, Inoue K, Katano S, Yokoi K.

Interact Cardiovasc Thorac Surg. 2008 Aug;7(4):573-7. doi: 10.1510/icvts.2007.174342. Epub 2008 Apr 15.

PMID:
18413349
8.

Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes.

Billiet C, De Ruysscher D, Peeters S, Decaluwé H, Vansteenkiste J, Dooms C, Deroose CM, De Leyn P, Hendrikx M, Bulens P, Le Péchoux C, Mebis J.

J Thorac Oncol. 2016 Sep;11(9):1538-49. doi: 10.1016/j.jtho.2016.05.037. Epub 2016 Jun 30.

9.

Postoperative radiotherapy for non-small cell lung cancer.

Burdett S, Rydzewska L, Tierney J, Fisher D, Parmar MK, Arriagada R, Pignon JP, Le Pechoux C; PORT Meta‐analysis Trialists Group.

Cochrane Database Syst Rev. 2016 Oct 11;10:CD002142. Review.

10.

Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.

Wang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB.

J Clin Oncol. 2015 Sep 1;33(25):2727-34. doi: 10.1200/JCO.2015.61.1517. Epub 2015 Jun 22.

PMID:
26101240
11.

Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).

Rieber J, Deeg A, Ullrich E, Foerster R, Bischof M, Warth A, Schnabel PA, Muley T, Kappes J, Heussel CP, Welzel T, Thomas M, Steins M, Dienemann H, Debus J, Hoffmann H, Rieken S.

Lung Cancer. 2016 Jan;91:41-7. doi: 10.1016/j.lungcan.2015.11.014. Epub 2015 Nov 25.

PMID:
26711933
12.

Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.

Kumar P, Herndon J 2nd, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.

Cancer. 1996 Jun 1;77(11):2393-9.

PMID:
8635112
13.

Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.

Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA.

J Thorac Oncol. 2015 Mar;10(3):462-71. doi: 10.1097/JTO.0000000000000411.

14.

Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database.

Corso CD, Rutter CE, Wilson LD, Kim AW, Decker RH, Husain ZA.

J Thorac Oncol. 2015 Jan;10(1):148-55. doi: 10.1097/JTO.0000000000000406.

15.

ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.

Decker RH, Langer CJ, Rosenzweig KE, Chang JY, Gewanter RM, Ginsburg ME, Kong FM, Lally BE, Videtic GM, Movsas B.

Am J Clin Oncol. 2011 Oct;34(5):537-44. doi: 10.1097/COC.0b013e318216e5a2. Review.

PMID:
21946673
16.

Radiation therapy for non-small cell lung cancer (NSCLC).

Choy H, Chakravarthy A, Kim JS.

Cancer Treat Res. 2001;105:121-48. Review. No abstract available.

PMID:
11224985
17.

Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.

Dai H, Hui Z, Ji W, Liang J, Lu J, Ou G, Zhou Z, Feng Q, Xiao Z, Chen D, Zhang H, Yin W, He J, Wang L.

Oncologist. 2011;16(5):641-50. doi: 10.1634/theoncologist.2010-0343. Epub 2011 Apr 11.

18.

Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.

Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA; Adjuvant Navelbine International Trialist Association.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):695-701. doi: 10.1016/j.ijrobp.2008.01.044. Epub 2008 Apr 24.

PMID:
18439766
19.

Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.

Urban D, Bar J, Solomon B, Ball D.

J Thorac Oncol. 2013 Jul;8(7):940-6. doi: 10.1097/JTO.0b013e318292c53e.

20.

Postoperative radiation therapy for non-small cell lung cancer.

Decker RH, Wilson LD.

Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):184-7. doi: 10.1053/j.semtcvs.2008.09.004. Review.

PMID:
19038726

Supplemental Content

Support Center